# Polymyxin B

NDC: 25021-196
Generic name: Polymyxin B Sulfate
Labeler / Manufacturer: Sagent Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS
Marketing started: 20251001

FDA application: ANDA207322

## Active ingredients

- POLYMYXIN B SULFATE: 500000 [USP'U]/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25021-196"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25021-196
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7dc505aa-64b0-4b7f-8ee3-2945bde40a34